Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends
Since the first clinical cancer treatment in 1978, photodynamic therapy (PDT) technologies have been largely improved and approved for clinical usage in various cancers. Due to the oxygen-dependent nature, the application of PDT is still limited by hypoxia in tumor tissues. Thus, the development of...
Main Authors: | Chun-Yan Shih, Pei-Ting Wang, Wu-Chou Su, Hsisheng Teng, Wei-Lun Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/2/137 |
Similar Items
-
Nanomedicines Targeting Tumor Cells or Tumor-Associated Macrophages for Combinatorial Cancer Photodynamic Therapy and Immunotherapy: Strategies and Influencing Factors
by: Wei Y, et al.
Published: (2024-10-01) -
All organic nanomedicine for PDT–PTT combination therapy of cancer cells in hypoxia
by: Anel Urazaliyeva, et al.
Published: (2024-07-01) -
Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine
by: Wei-Peng Li, et al.
Published: (2021-01-01) -
Innovative strategies for photodynamic therapy against hypoxic tumor
by: Xiaotong Li, et al.
Published: (2023-01-01) -
Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy
by: Jooho Park, et al.
Published: (2021-01-01)